These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2509709)

  • 21. N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2.
    Malamas MS; Hohman TC
    J Med Chem; 1994 Jun; 37(13):2059-70. PubMed ID: 8027987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of potent aldose reductase inhibitors having a hydantoin structure.
    Miwa I; Hirano M; Inagaki K; Belbeoc'h C; Okuda J
    Biochem Pharmacol; 1987 Sep; 36(17):2789-94. PubMed ID: 3115267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of erythrocyte anion exchange by tolrestat, an inhibitor of aldose reductase.
    Gunn RB; Gunn HB
    Metabolism; 1989 Aug; 38(8):801-4. PubMed ID: 2503683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and aldose reductase-inhibitory activity of benzo[b]furan derivatives possessing a carboxymethylsulfamoyl group.
    Ohishi Y; Mukai T; Nagahara M; Yajima M; Kajikawa N
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2398-405. PubMed ID: 2514045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spiro hydantoin aldose reductase inhibitors.
    Sarges R; Schnur RC; Belletire JL; Peterson MJ
    J Med Chem; 1988 Jan; 31(1):230-43. PubMed ID: 3121857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (Pyrimidinyloxy)acetic acids and pyrimidineacetic acids as a novel class of aldose reductase inhibitors.
    Ellingboe J; Alessi T; Millen J; Sredy J; King A; Prusiewicz C; Guzzo F; VanEngen D; Bagli J
    J Med Chem; 1990 Oct; 33(10):2892-9. PubMed ID: 2120443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M; Robison WG
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.
    Calcutt NA; Mizisin AP; Kalichman MW
    Eur J Pharmacol; 1994 Jan; 251(1):27-33. PubMed ID: 8137868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats.
    Notvest RR; Inserra JJ
    Diabetes; 1987 Apr; 36(4):500-4. PubMed ID: 3102300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged fructose feeding and aldose reductase inhibition: effect on the polyol pathway in kidneys of normal rats.
    Bellomo G; Comstock JP; Wen D; Hazelwood RL
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):348-54. PubMed ID: 3122222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N- and 2-substituted N-(phenylsulfonyl)glycines as inhibitors of rat lens aldose reductase.
    DeRuiter J; Borne RF; Mayfield CA
    J Med Chem; 1989 Jan; 32(1):145-51. PubMed ID: 2491890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve.
    Brett FM; Kalichman MW; Calcutt NA; Mizisin AP
    J Neurol Sci; 1996 Sep; 141(1-2):6-12. PubMed ID: 8880685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
    DeRuiter J; Brubaker AN; Millen J; Riley TN
    J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.